Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-30.77
Price to sales ratio
13.04

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
549
DGX
Quest Diagnostics Incorporated Common Stock
207.38 USD-0.02%-3.80%+1.02%+23.35%22.96 B USD
554
LH
Labcorp Holdings Inc. Common Stock
276.51 USD-0.10%-3.75%+3.61%-0.94%22.67 B USD
695
MEDP
Medpace Holdings, Inc. - Common Stock
530.19 USD-1.49%-4.72%+11.18%-12.59%15.14 B USD
776
ICLR
ICON plc - Ordinary Shares
166.10 USD-0.97%-3.45%+12.50%+11.57%12.72 B USD

Frequently asked questions about Guardant Health, Inc. - Common Stock

What is the Guardant Health, Inc. - Common Stock stock price today?

The current price of Guardant Health, Inc. - Common Stock (GH) is 158.4. Over the past 24 hours, the stock has changed by -1.03%. Follow the GH chart for real-time price dynamics.

What is the stock ticker of Guardant Health, Inc. - Common Stock?

Guardant Health, Inc. - Common Stock trades under the ticker GH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Guardant Health, Inc. - Common Stock stock going up?

GH has changed by -6.11% over the last week, +18.82% over the last month, and +118.30% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Guardant Health, Inc. - Common Stock net income for the last quarter?

Guardant Health, Inc. - Common Stock reported net income of -112.08 M for the last quarter. The previous quarter showed -128.49 M, which means net income changed by +12.78%.

How many employees does Guardant Health, Inc. - Common Stock have?

As of the latest available data, Guardant Health, Inc. - Common Stock has 2 506 employees. Workforce size can provide additional context about the company's scale and operations.

What is Guardant Health, Inc. - Common Stock EBITDA?

Guardant Health, Inc. - Common Stock EBITDA is -111.91 M, and its EBITDA margin is -37.1%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Guardant Health, Inc. - Common Stock stock?

You can buy Guardant Health, Inc. - Common Stock (GH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Guardant Health, Inc. - Common Stock stock?

Investing in Guardant Health, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GH chart and related analysis on metatrader.com as part of your research.

Guardant Health, Inc. - Common Stock

Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.

News